| Early renin‐angiotensin system intervention is more beneficial than late intervention in delaying end‐stage renal disease in patients with type 2 diabetes B Schievink, T Kröpelin, S Mulder, HH Parving, G Remuzzi, J Dwyer, ... Diabetes, Obesity and Metabolism 18 (1), 64-71, 2016 | 82 | 2016 |
| The renal protective effect of angiotensin receptor blockers depends on intra‐individual response variation in multiple risk markers B Schievink, D de Zeeuw, HH Parving, P Rossing, HJ Lambers Heerspink British journal of clinical pharmacology 80 (4), 678-686, 2015 | 68 | 2015 |
| Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days V Starokozhko, S Vatakuti, B Schievink, MT Merema, A Asplund, ... Archives of toxicology 91, 2079-2092, 2017 | 51 | 2017 |
| Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers B Schievink, D De Zeeuw, PA Smink, D Andress, JJ Brennan, B Coll, ... European journal of preventive cardiology 23 (7), 758-768, 2016 | 42 | 2016 |
| The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders B Schievink, H Lambers Heerspink, H Leufkens, D De Zeeuw, J Hoekman PLoS One 9 (9), e108722, 2014 | 16 | 2014 |
| Surrogate endpoints in clinical trials of chronic kidney disease progression: moving from single to multiple risk marker response scores B Schievink, PGM Mol, HJL Heerspink Current Opinion in Nephrology and Hypertension 24 (6), 492-497, 2015 | 6 | 2015 |
| Erratum to: Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days V Starokozhko, S Vatakuti, B Schievink, MT Merema, A Asplund, ... Archives of toxicology 91 (7), 2711, 2016 | 3 | 2016 |
| Heart failure induced by aleglitazar treatment can be predicted based on short-term response in multiple risk markers B Schievink, D Grobbee, A Michael Lincoff Submitted for publication, 0 | 2 | |
| Integrating biomarkers to predict renal and cardiovascular drug efficacy: PRE score applications from drug registration to personalized medicine B Schievink | | 2016 |
| Model development to predict long-term ESRD outcomes ST Mulder, BH Schievink, TF Kropelin, P Vemer, HJL Heerspink, ... Faculty of Science and Engineering, 2014 | | 2014 |
| Integrating biomarkers to predict renal and cardiovascular drug efficacy B Schievink | | |
